All In Biotech

Drug Trial Radar · NCT07584967

A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of 2 Dose Levels of the Oral Ghrelin Receptor Agonist AC01 Over 12 Weeks in Patients With Chronic Advanced Heart Failure With Reduced Ejection Fraction (HFrEF)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Nov 15, 2026

Primary completion

Jul 30, 2028

Study completion Aug 30, 2028

Sponsor

Lead sponsor
AnaCardio ABIndustry
Sponsor type
Industry
First posted
May 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanced HFrEF.

Conditions

  • Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

  • AC01Drug

    AC01 tablets for oral administration.

  • PlaceboOther

    AC01 matching placebo tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change from Baseline in Composite Echocardiography Z-Score at Week 12Time frame: Baseline and Week 12

Locations

14 sites in 8 countries. Site status is shown where the registry gives one.

  • Progressive MD, InvivoCure

    Van Nuys, California · Recruiting

  • Nature Coast Clinical Research

    Crystal River, Florida · Recruiting

  • Chicago Cardiology Institute

    Schaumburg, Illinois · Recruiting

  • Capital Area Research, LLC - Camp Hill

    Camp Hill, Pennsylvania · Recruiting

  • Multi-Profile Hospital for Active Treatment (MHAT) - Hospital Puls

    Blagoevgrad, Bulgaria · Recruiting

  • Medical Center I - Burgas

    Burgas, Bulgaria · Recruiting

  • Medical Center Medconsult Pleven

    Pleven, Bulgaria · Recruiting

  • Diex Recherche Trois-Rivières

    Trois-Rivières, Canada · Recruiting

  • Diex Recherche Sherbrooke

    Sherbrooke, Québec (QC), Canada · Recruiting

  • Kardio Michal Čepelák, s.r.o.

    Klatovy, Czechia · Recruiting

  • Medicome Sp z o.o. Oswiecimskie Centrum Medyczne

    Oświęcim, Poland · Recruiting

  • MUDr. Daniela Viňanská Interná a kardiologická ambulancia, Medispol, s.r.o

    Prešov, Slovakia · Recruiting

  • Hospital SON LLATZER

    Palma, Spain · Recruiting

  • Sahlgrenska Universitetssjukhuset

    Gothenburg, Sweden · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.